載入...
Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection
Respiratory Syncytial Virus (RSV) infects almost all children under the age of one and is the leading cause of hospitalization among infants. Despite several decades of research with dozens of candidate vaccines being vigorously evaluated in pre-clinical and clinical studies, there is no licensed va...
Na minha lista:
| 發表在: | Sci Rep |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6226510/ https://ncbi.nlm.nih.gov/pubmed/30413743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-34999-z |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|